瞬态弹性成像
医学
内科学
失代偿
肝活检
队列
2型糖尿病
前瞻性队列研究
肝纤维化
2型糖尿病
糖尿病
队列研究
肝病
胃肠病学
糖化血红素
脂肪肝
脂肪变性
活检
丙型肝炎
外科
肝病学
纤维化
试验预测值
回顾性队列研究
非酒精性脂肪肝
代谢综合征
作者
Yuping Chen,Bingtian Dong,Xinrui Jin,Chuan Liu,Ming-Hua Zheng,Xiao Liang,Yameng Sun,Hye Won Lee,Huapeng Lin,Emmanuel Tsochatzis,Salvatore Petta,Elisabetta Bugianesi,Masato Yoneda,Hannes Hagström,Jérôme Boursier,Calleja Jl,George Boon-Bee Goh,W. F. Chan,Rocio Gallego-Durán,Arun J Sanyal
出处
期刊:Gut
[BMJ]
日期:2026-01-21
卷期号:75 (3): 576-587
被引量:3
标识
DOI:10.1136/gutjnl-2025-337506
摘要
BACKGROUND: Current guidelines recommend a two-step approach for risk stratification of metabolic dysfunction-associated steatotic liver disease (MASLD), starting with Fibrosis-4 index (FIB-4) followed by liver stiffness measurement (LSM) using vibration-controlled transient elastography (VCTE). OBJECTIVE: To evaluate this approach for predicting advanced fibrosis and liver-related events (LREs) in patients with type 2 diabetes (T2D). DESIGN: A prospective liver biopsy cohort of T2D patients with histologically confirmed MASLD from seven centres in China was used to assess diagnostic performance for advanced fibrosis. The international VCTE-Prognosis cohort, including T2D patients with MASLD who underwent VCTE at 16 centres in the USA, Europe and Asia, with longitudinal follow-up, was used to assess LREs, defined as hepatic decompensation or hepatocellular carcinoma. RESULTS: 4781 participants were included. In the liver biopsy cohort (n=352; 22.2% with advanced fibrosis), applying LSM thresholds of <8 kPa and >12 kPa after FIB-4 classified patients into 63.4% low-risk, 9.4% intermediate-risk and 27.3% high-risk, with a correct classification rate of 71%. In the VCTE-Prognosis cohort (n=4429; median follow-up 51.3 (IQR 27.4-70.7) months), 140 (3.2%) patients developed LREs (110 (2.5%) with hepatic decompensation and 59 (1.3%) with hepatocellular carcinoma). The two-step approach classified 72.6%, 6.8% and 20.6% of patients into low-risk, intermediate-risk and high-risk groups, with corresponding 5-year cumulative LRE incidences of 0.7%, 0.9% and 11.8%. Refining classification of intermediate FIB-4 patients using LSM <10 kPa (low-risk) and >15 kPa (high-risk) reduced the intermediate-risk group to 5.6% while preserving predictive accuracy. CONCLUSION: The non-invasive two-step approach of FIB-4 followed by LSM effectively stratifies MASLD-related advanced fibrosis and LREs risk in T2D. Applying LSM cut-offs of 10 and 15 kPa further optimises risk stratification for future LREs.
科研通智能强力驱动
Strongly Powered by AbleSci AI